Perrigo Company plc Ordinary Shares (PRGO): Price and Financial Metrics
Perrigo Company plc Ordinary Shares (PRGO)
Today's Latest Price: $52.63 USD
Updated Aug 13 5:15pm
Add PRGO to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 215 in Medical - Pharmaceuticals
See all "A" rated Strong Buy stocks
PRGO Stock Summary
- With a one year PEG ratio of 596.26, PERRIGO Co plc is expected to have a higher PEG ratio (a measure of how expensive a stock is relative to its expected earnings growth) than 93.87% of US stocks.
- PERRIGO Co plc's stock had its IPO on December 17, 1991, making it an older stock than 82.43% of US equities in our set.
- In terms of volatility of its share price, PRGO is more volatile than only 3.59% of stocks we're observing.
- Stocks that are quantitatively similar to PRGO, based on their financial statements, market capitalization, and price volatility, are BDC, HRC, LNDC, CUB, and BDX.
- PRGO's SEC filings can be seen here. And to visit PERRIGO Co plc's official web site, go to www.perrigo.com.
PRGO Stock Price Chart Technical Analysis Charts
PRGO Price/Volume Stats
| Current price | $52.63 | 52-week high | $63.86 |
| Prev. close | $53.22 | 52-week low | $40.01 |
| Day low | $52.54 | Volume | 675,856 |
| Day high | $53.59 | Avg. volume | 1,114,013 |
| 50-day MA | $54.76 | Dividend yield | 1.69% |
| 200-day MA | $53.12 | Market Cap | 7.18B |
Perrigo Company plc Ordinary Shares (PRGO) Company Bio
Perrigo Company develops, manufactures, and distributes generic prescription pharmaceuticals, infant formulas, nutritional products, active pharmaceutical ingredients and pharmaceutical and medical diagnostic products. The company was founded in 1887 and is based in Dublin, Ireland.
PRGO Price Forecast Based on DCF Valuation
| Current Price | DCF Fair Value Target: | Forecasted Gain: |
| $52.63 | $36.92 | -30% |
We started the process of determining a valid price forecast for PERRIGO Co plc with a discounted cash flow analysis -- the results of which can be found in the table below. To summarize, we found that PERRIGO Co plc ranked in the 38th percentile in terms of potential gain offered. We should note, though, that all scenearios modelled for this stock suggest it is overvalued. As for the metrics that stood out in our discounted cash flow analysis of PERRIGO Co plc, consider:
- The stock's equity weight, or the proportion of capital from equity relative to debt, is 64. Its equity weight surpasses that of only 20.79% of free cash flow generating stocks in the Healthcare sector.
- The company's compound free cash flow growth rate over the past 5.75 years comes in at -0.02%; that's greater than merely 22.76% of US stocks we're applying DCF forecasting to.
- PERRIGO Co plc's weighted average cost of capital (WACC) is 7%; for context, that number is higher than only 9.41% of tickers in our DCF set.
| Terminal Growth Rate in Free Cash Flow | Return Relative to Current Share Price |
| 0% | -32% |
| 1% | -31% |
| 2% | -30% |
| 3% | -30% |
| 4% | -29% |
| 5% | -28% |
Want more companies with a valuation profile/forecast similar to that of PERRIGO Co plc? See IQV, LMAT, ITGR, NVS, and BDX.
Loading social stream, please wait...